This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Policy Statement

US Preventive Services Task Force

JAMA. 1993;270(23):2846-2848.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

SUMMARY OF RECOMMENDATION

There is currently little evidence from published clinical research to suggest that routine iron supplementation during pregnancy is beneficial in improving clinical outcomes for the mother, fetus, or newborn. The evidence is insufficient to recommend for or against routine iron supplementation during pregnancy ("C" recommendation). Although observational data (grade II-2 evidence) suggest that pregnant women with anemia (hemoglobin level less than 100 g/L) are at increased risk of preterm birth, low birth weight, and other adverse outcomes, it is unclear from such evidence whether anemia is responsible for these outcomes and whether they can be prevented through iron supplementation. Similarly, it is unclear whether iron supplementation during pregnancy can reduce the incidence of iron deficiency in infants, a condition that has been associated with delayed psychomotor development. Although iron supplementation can improve maternal hematologic indexes, controlled clinical trials (grade I and II-1 evidence) have failed to demonstrate . . . [Full Text PDF of this Article]

Footnotes
Reprint requests to the Office of Disease Prevention and Health Promotion, US Public Health Service, 330 C St SW, Room 2132, Switzer Bldg, Washington, DC 20201 (Steven H. Woolf, MD, MPH).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?